Fate Therapeutics (FATE) Debt to Equity (2012 - 2019)
Fate Therapeutics (FATE) reported Debt to Equity of $0.05 for Q3 2019, down 39.18% on a YoY basis from $0.09 in Q3 2018, and down 55.56% quarter-over-quarter from $0.12 in Q2 2019.
Fate Therapeutics (FATE) Debt to Equity (2012 - 2019) Analysis & Trends
Fate Therapeutics has reported Debt to Equity for 8 years, with the latest figure at $0.05 in Q3 2019.
- For the quarter ending Q3 2019, Debt to Equity fell 39.18% year-over-year to $0.05; the trailing twelve-month figure through Sep 2019 stood at $0.05 (down 39.18% YoY), and the FY2018 full-year result was $0.09, down 51.65% from the prior year.
- Debt to Equity for Q3 2019 stood at $0.05, down from $0.12 in the prior quarter.
- The five-year high for Debt to Equity was $0.93 in Q1 2015, with the low at $0.05 in Q3 2019.
- Historically, Debt to Equity has averaged $0.3 across 5 years, with a median of $0.23 in 2018.
- Annual changes were most pronounced in 2015 — Debt to Equity jumped 3272.26% — and 2017, when it plunged 80.9%.
- Fate Therapeutics' Debt to Equity stood at $0.48 in 2015, then slumped by 69.53% to $0.15 in 2016, then surged by 31.31% to $0.19 in 2017, then plunged by 51.65% to $0.09 in 2018, then tumbled by 43.96% to $0.05 in 2019.
- The last three Debt to Equity figures came in at $0.05 (Q3 2019), $0.12 (Q2 2019), and $0.1 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 0.05 |
| Jun 30, 2019 | 0.12 |
| Mar 31, 2019 | 0.10 |
| Dec 31, 2018 | 0.09 |
| Sep 30, 2018 | 0.09 |
| Jun 30, 2018 | 0.29 |
| Mar 31, 2018 | 0.23 |
| Dec 31, 2017 | 0.19 |
| Sep 30, 2017 | 0.32 |
| Jun 30, 2017 | 0.12 |
| Mar 31, 2017 | 0.14 |
| Dec 31, 2016 | 0.15 |
| Sep 30, 2016 | 0.50 |
| Jun 30, 2016 | 0.63 |
| Mar 31, 2016 | 0.54 |
| Dec 31, 2015 | 0.48 |
| Sep 30, 2015 | 0.43 |
| Jun 30, 2015 | 0.39 |
| Mar 31, 2015 | 0.93 |
| Dec 31, 2014 | 0.69 |